Publications

Estimating cellular pathways from an ensemble of heterogeneous data sources

Authors: A Franks, F Markowetz, E Airoldi

Research group: Markowetz Group

E-pub date: 23 Jun 2014

Journal name:

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.

Authors: V Zecchini, B Madhu, R Russell, N Pértega-Gomes, A Warren, E Gaude, J Borl...

Research group:

E-pub date: 17 Jun 2014

Journal name: EMBO J

CtIP-mediated resection is essential for viability and can operate independently of BRCA1.

Authors: F Polato, E Callen, N Wong, R Faryabi, S Bunting, H-T Chen, M Kozak, MJ Kru...

Research group: Jackson Group

E-pub date: 2 Jun 2014

Journal name: J Exp Med

The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.

Authors: Z Ji, H Mohammed, A Webber, J Ridsdale, N Han, JS Carroll, AD Sharrocks

Research group: Carroll Group

E-pub date: 1 Jun 2014

Journal name: Nucleic Acids Res

OC-016 The Toll-like Receptor Pathway Is Recurrently Mutated In Oesophageal Adenocarcinoma

Authors: F Elliott, C Ross-Innes, Eldridge, R Fitzgerald

Research group: Bioinformatics

E-pub date: 1 Jun 2014

Journal name: Gut

PTU-153 The Timing Of Oncogenic Events In The Evolution Of The Oesophageal Adenocarcinoma Genome And Implications For Clinical Diagnostics.

Authors: J Weaver, C Ross-Innes, N Shannon, A Lynch, M Murtaza, T Forshew, M Dunning...

Research group: Bioinformatics,

E-pub date: 1 Jun 2014

Journal name: Gut

USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism.

Authors: PA Knobel, R Belotserkovskaya, Y Galanty, CK Schmidt, SP Jackson, TH Strack...

Research group: Jackson Group

E-pub date: 1 Jun 2014

Journal name: Mol Cell Biol

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Authors: WJ Howat, FM Blows, E Provenzano, MN Brook, L Morris, P Gazinska, N Johnson...

Research group: Ali Group

E-pub date: 1 Jun 2014

Journal name: The Clinical Journal of Pathology

Filters

Research Groups

Core Facilities

Start date

End date

Estimating cellular pathways from an ensemble of heterogeneous data sources

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.

CtIP-mediated resection is essential for viability and can operate independently of BRCA1.

The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.

OC-016 The Toll-like Receptor Pathway Is Recurrently Mutated In Oesophageal Adenocarcinoma

PTU-153 The Timing Of Oncogenic Events In The Evolution Of The Oesophageal Adenocarcinoma Genome And Implications For Clinical Diagnostics.

USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Estimating cellular pathways from an ensemble of heterogeneous data sources

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.

CtIP-mediated resection is essential for viability and can operate independently of BRCA1.

The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.

OC-016 The Toll-like Receptor Pathway Is Recurrently Mutated In Oesophageal Adenocarcinoma

PTU-153 The Timing Of Oncogenic Events In The Evolution Of The Oesophageal Adenocarcinoma Genome And Implications For Clinical Diagnostics.

USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium